Radiopharmaceutical developer Navidea Biopharmaceuticals has released its fourth quarter and 2012 fiscal year (end-December 31) financial results.
The company reported revenues of $6.8 million for the quarter. Navidea also reported a net loss of $7.2 million for the fourth quarter of 2012, compared with $7.6 million in 2011.
For the year, Navidea had revenues of $79,000, compared with $598,000 in 2011. Net loss for the year was $29.2 million, compared with income of $5.6 million in 2011.
